Clinical Trials in Malang, Indonesia
Locations / Malang, Indonesia
Delta Trials hosts 52 clinical trials conducted in Malang, Indonesia, making it a notable site of clinical research activity. These trials covering 86 medical conditions and multiple therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 4 trials in this location have been stopped, mirroring broader trends in global research activity. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, tracking research history across multiple versions for Malang.
52
Total Trials
86
Conditions
4
Terminated since 2020
Browse by condition (86 total)
- Type 2 diabetes 3 trialsAll Type 2 diabetes trials
- COVID-19 3 trialsAll COVID-19 trials
- Atrial fibrillation 3 trialsAll Atrial fibrillation trials
- Type 2 diabetes mellitus 2 trialsAll Type 2 diabetes mellitus trials
- Systemic lupus erythematosus 2 trialsAll Systemic lupus erythematosus trials
- Cardiovascular diseases 2 trialsAll Cardiovascular diseases trials
- Rheumatoid arthritis 2 trialsAll Rheumatoid arthritis trials
- Cigarette smoking 2 trialsAll Cigarette smoking trials
- Diabetes mellitus, type 2 2 trialsAll Diabetes mellitus, type 2 trials
- Linear programming 2 trialsAll Linear programming trials
- Sle (systemic lupus) 1 trialAll Sle (systemic lupus) trials
- Workplace interventions 1 trialAll Workplace interventions trials
- Pacemaker complication 1 trialAll Pacemaker complication trials
- Wellness program 1 trialAll Wellness program trials
- Sleep disturbance 1 trialAll Sleep disturbance trials
- Nutrigenetic 1 trialAll Nutrigenetic trials
- Coronary artery disease 1 trialAll Coronary artery disease trials
- Oxidative stress 1 trialAll Oxidative stress trials
- Enterocolitis, necrotizing 1 trialAll Enterocolitis, necrotizing trials
- Insulin resistance 1 trialAll Insulin resistance trials